WEHI-3 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The WEHI-3 cell line is a murine leukemia cell line, specifically derived from the BALB/c strain. It was originally established from a spontaneous myelomonocytic leukemia found in a mouse. This cell line is extensively used as a model to study myeloid differentiation and the immune response, particularly the mechanisms underlying leukemia progression and the response of leukemic cells to various treatments. WEHI-3 cells are capable of producing interleukin-3 (IL-3) and are often used in research as a source of this cytokine. In laboratory settings, WEHI-3 cells have been employed to assess the differentiation potential of various compounds and the biological activities that modulate the hematopoietic system. These cells have proven instrumental in understanding how alterations in gene expression affect myeloid cells, serving as a critical tool in the development of therapeutic strategies against myeloid leukemias. The cell line is also used in vivo to establish murine models of disease through transplantation into susceptible mouse strains, enabling studies of tumor progression and the efficacy of anti-cancer agents. |
|---|---|
| Organism | Mouse |
| Tissue | Peripheral blood |
| Disease | Leukemia |
| Synonyms | WEHI 3, WEHI3, Wehi-3 |
Characteristics
| Breed/Subspecies | BALB/c |
|---|---|
| Morphology | Macrophage-like |
| Cell type | Myelomonocyte |
| Growth properties | Suspension |
Regulatory Data
| Citation | WEHI-3 (Cytion catalog number 400381) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_3622 |
Biomolecular Data
| Receptors expressed | Immunoglobulin (Fc), complement (C3) |
|---|---|
| Viruses | Ectromelia virus (mousepox) negative |
| Products | Lysozyme, granulocyte colony stimulating activity (G-CSA), interleukin-3 (interleukin 3, IL-3) |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 x 105 cells/ml and maintain between 3 x 105 and 1x106 cells/ml. Adherent cells can be recovered by scraping. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
-
Related products
Related products